Effect of the mucolytic erdosteine on the success rate of PPI-based first-line triple therapy for Helicobacter pylori eradication: a prospective, double-blind, randomized, placebo-controlled study

References

• Windsor HM, O'Rourke J. Bacteriology and taxonomy of Helicobacter pylori. Gastroenterol Clin North Am 2000;29:633–48.
   PubMedGoogle Scholar
• Go MF, Crowe SE. Virulence and pathogenicity of Helicobacter pylori. Gastroenterol Clin North Am 2000;29:649–70.
   PubMed Web of Science ®Google Scholar
• Cohen H. Peptic ulcer and Helicobacter pylori. Gastroenterol Clin North Am 2000;29:775–89.
   PubMed Web of Science ®Google Scholar
• Fontham ET, Ruiz B, Perez A, Hunter F, Correa P. Determinants of Helicobacter pylori infection and chronic gastritis. Am J Gastroenterol 1995;90:1094–101.
   PubMed Web of Science ®Google Scholar
• Morgner A, Bayerdörffer E, Neubauer A, Stolte M. Malignant tumors of the stomach. Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori. Gastroenterol Clin North Am 2000;29:593–607.
   PubMedGoogle Scholar
• Eslick GD, Lim LL, Byles JE, Xia HH, Talley NJ. Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol 1999;94:2373–9.
   PubMed Web of Science ®Google Scholar
• Kearney DJ. Retreatment of Helicobacter pylori infection after initial treatment failure. Am J Gastroenterol 2001;96:1335–9.
   PubMedGoogle Scholar
• O'Connor A, Gisbert J, O'Morain C. Treatment of Helicobacter pylori infection. Helicobacter 2009;14 (Suppl 1):46–51.
   PubMedGoogle Scholar
• Zou J, Dong J, Yu X. Meta-analysis: lactobacillus containing quadruple therapy versus standard triple first-line therapy for Helicobacter pylori eradication. Helicobacter 2009;14:97–107.
   PubMed Web of Science ®Google Scholar
• Szajewska H, Albrecht P, Topczewska-Cabanek A. Randomized, double-blind, placebo-controlled trial: effect of lactobacillus GG supplementation on Helicobacter pylori eradication rates and side effects during treatment in children. J Pediatr Gastroenterol Nutr 2009;48:431–6.
   PubMed Web of Science ®Google Scholar
• Sezikli M, Cetinkaya ZA, Sezikli H, Güzelbulut F, Tiftikçi A, Ince AT, Oxidative stress in Helicobacter pylori infection: does supplementation with vitamins C and E increase the eradication rate? Helicobacter 2009;14:280–5.
   PubMed Web of Science ®Google Scholar
• Hazell SL, Lee A, Brady L, Hennessy W. Campylobacter pyloridis and gastritis: association with intercellular spaces and adaptation to an environment of mucus as important factors in colonization of the gastric epithelium. J Infect Dis 1986;153:658–63.
   PubMed Web of Science ®Google Scholar
• Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996;20:1161–81.
   PubMed Web of Science ®Google Scholar
• Technical annex: tests used to assess Helicobacter pylori infection. Working Party of the European Helicobacter pylori Study Group. Gut 1997;41 (Suppl 2):S10-8.
   PubMedGoogle Scholar
• Gumurdulu Y, Serin E, Ozer B, Kayaselcuk F, Ozsahin K, Cosar AM, Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey. World J Gastroenterol 2004;10:668–71.
   PubMed Web of Science ®Google Scholar
• Kadayifci A, Buyukhatipoglu H, Cemil Savas M, Simsek I. Eradication of Helicobacter pylori with triple therapy: an epidemiologic analysis of trends in Turkey over 10 years. Clin Ther 2006;28:1960–6.
   PubMed Web of Science ®Google Scholar
• Simsek H, Balaban YH, Gunes DD, Hascelik G, Ozarlan E, Tatar G. Alarming clarithromycin resistance of Helicobacter pylori in Turkish population. Helicobacter 2005;10:360–1.
   PubMedGoogle Scholar
• Zala G, Flury R, Wüst J, Meyenberger C, Ammann R, Wirth HP. Omeprazole/amoxicillin: improved eradication of Helicobacter pylori in smokers because of N-acetylcysteine. Schweiz Med Wochenschr 1994;124:1391–7.
   PubMedGoogle Scholar
• Gurbuz AK, Ozel AM, Ozturk R, Yildirim S, Yazgan Y, Demirturk L. Effect of N-acetyl cysteine on Helicobacter pylori. South Med J 2005;98:1095–7.
   PubMed Web of Science ®Google Scholar
• Gotoh A, Akamatsu T, Shimizu T, Shimodaira K, Kaneko T, Kiyosawa K, Additive effect of pronase on the efficacy of eradication therapy against Helicobacter pylori. Helicobacter 2002;7:183–91.
   PubMedGoogle Scholar
• Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007;56:772–81.
   PubMed Web of Science ®Google Scholar
• Dechant KL, Noble S. Erdosteine. Drugs 1996;52:875–81.
   PubMed Web of Science ®Google Scholar
• Marchioni CF, Moretti M, Muratori M, Casadei MC, Guerzoni P, Scuri R, Effects of erdosteine on sputum biochemical and rheologic properties: pharmacokinetics in chronic obstructive lung disease. Lung 1990;168:285–93.
   PubMed Web of Science ®Google Scholar
• Ricevuti G, Mazzone A, Uccelli E, Gazzani G, Fregnan GB. Influence of erdosteine, a mucolytic agent, on amoxycillin penetration into sputum in patients with an infective exacerbation of chronic bronchitis. Thorax 1988;43:585–90.
   PubMed Web of Science ®Google Scholar
• Carlstedt I, Sheehan JK. Is the macromolecular architecture of cervical, respiratory and gastric mucins the same? Biochem Soc Trans 1984;12:615–17.
   PubMed Web of Science ®Google Scholar